共 153 条
[1]
Hiromatsu Y(2014)Graves ophthalmopathy: epidemiology and natural history Intern Med 53 353-360
[2]
Eguchi H(2009)Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy Acta Ophthalmol 87 58-64
[3]
Tani J(2004)Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone Br J Ophthalmol 88 1380-1386
[4]
Kasaoka M(2008)Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series Eye (Lond). 22 311-315
[5]
Teshima Y(2011)Clinical review: intravenous glucocorticoids for graves’ Orbitopathy: efficacy and morbidity J Clin Endocrinol Metab 96 320-332
[6]
Bordaberry M(2006)Avoiding surgery for thyroid eye disease Eye (Lond) 20 1171-1177
[7]
Marques DL(2000)Randomized placebo-controlled study of radiotherapy for graves’ ophthalmopathy Lancet 355 1505-1509
[8]
Pereira-Lima JC(2004)A randomized controlled trial of orbital radiotherapy versus sham irradiatation in patients with mild graves’ ophthalmopathy J Clin Endocrinol Metab 89 15-20
[9]
Marcon IM(2012)Feldt- Rasmussen U, Orgiazzi J, et al. fatal and non- fatal adverse events of glucocorticoid therapy for graves’ orbitopathy: a questionnaire survey among members of the European thyroid association Eur J Endocrinol 166 247-253
[10]
Schmid H(2001)Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe graves’ ophthalmopathy: results of a prospective, single-blind, randomized study J Clin Endocrinol Metab 86 3562-3567